Joshua Horowitz

Director Joshua Horowitz purchases 4,500 shares at $9.92 avg; holds 372,000 shares post-buy in recently-listed KWY

Joshua Horowitz, Director of KINGSWAY Corp, executed 2 separate purchases totaling 4,500 shares (4.5K shares) for $44,624.90 ($44.6K) on 2026-05-28 and 2026-05-29 at a blended average price of $9.92. The stock is currently trading at $10.00 as of 2026-06-01, just 8 trading days after listing, making recent price history unavailable for comparison. Post-transaction, Horowitz holds 372,000 shares (372.0K shares), representing a +1.2% increase versus his pre-transaction holdings of 367,500 shares (367.5K shares). The company reported latest-quarter revenue of $38,959,000.00 ($39.0M) but posted net income of $-2,268,000.00 ($-2.3M), with annual revenue growth of +23.4% year-over-year; however, the company was unprofitable over its most recent full fiscal year. As an early post-listing transaction from a director with a substantial existing position, this purchase warrants monitoring for patterns of insider participation as the company's profitability trajectory develops.

Director Horowitz purchases 4,433 shares at $1.05 (4th buy in 15 months; prior BRN buys underperformed at 90d).

Joshua Horowitz acquired 4,433 shares at $1.05, expanding his stake by 1.4% to 319,709 shares total. This is his fourth purchase of BRN stock within 15 months, following earlier buys on 2025-11-24 and 2024-08-21/23. However, his same-ticker history at BRN shows a consistent pattern of underperformance: all four prior buys registered negative or flat 90-day returns, with cumulative 90-day outcomes of -8.2%, -8.2%, -26.6%, and -24.6%. The current stock price of $1.14 is down 10.2% over 90 days and trades 42.4% below its 52-week high. The company faces operational headwinds: revenue declined 37.0% year-over-year, the latest quarter posted a $-1.4M net loss, and market cap stands at $14.3M with negative full-year earnings. Repeated accumulation at a small-cap trading well below prior highs, combined with a persistent pattern of 90-day underperformance on this ticker and deteriorating fundamentals, suggests a speculative holding rather than a vote of operational confidence.

Director Horowitz buys 59,563 shares at $1.10 in 2 transactions; holdings up 23.3% to 315.3K shares amid -41.9% drawdown from 52-week high

Joshua Horowitz, Director at Barnwell Industries, made 2 separate open-market purchases totaling 59,563 shares for $65,519.30 at $1.10 per share on 2025-11-24, expanding his holdings by 23.3% to 315.3K shares. The current stock price of $1.15 is -41.9% from its 52-week high and -5.0% over the past 30 days, placing the purchases near recent lows. However, Horowitz's prior trades at BRN show mixed timing: his 2 previous buys (August 2024) generated -0.0% and +2.6% 30-day returns but declined -26.6% and -24.6% over 90 days, with 0 of 2 prior buys well-timed at the 90-day mark. The company reported a net loss of $1,550,000.00 in the latest quarter and -14.0% annual revenue decline, with unprofitable full-year results. A cluster pattern is present with 2 other insiders also buying within the past 14 days, suggesting coordinated activity rather than isolated conviction.

Director Horowitz sells 25.4K LMB shares ($1.9M) at $75.43; post-sale holdings 164.6K (-13.4%)

Horowitz sold 25,400 shares at $75.43 on 2025-03-14, reducing his holdings by 13.4% to 164,600 shares and generating $1,915,909.30 in proceeds. His prior trades at LMB show a consistent pattern: five prior sells between September 6-9, 2024, all of which experienced substantial gains afterward (90-day returns ranging from 49.8% to 63.6%), with 0 of 5 prior sells well-timed at the 90-day mark. The current price of $76.51 is 30.4% below the 52-week high of $105.33, and stock has declined 16.3% over 30 days and 18.9% over 90 days since this transaction. The company shows modest fundamentals: $133.9M quarterly revenue, $7.5M net income, and only 0.5% annual revenue growth, with a P/E of 23.83.

LMB Director Joshua Horowitz sells 20,000 shares (9.5% of holdings) for $1.2M across 7 transactions.

Joshua Horowitz, a director at Limbach Holdings, completed 7 separate sales totaling 20,000 shares (20.0K shares) for $1,244,612.32 between September 5–9, 2024, at a blended average price of $62.23, reducing his holdings from 210,000 shares to 190,000 shares. The stock currently trades at $64.47, near its 52-week high of $65.39, and has appreciated +8.7% over 30 days and +13.1% over 90 days. His prior trades at LMB comprised 5 sales in mid-August 2024, all too recent for outcome measurement, providing no same-ticker timing history. Across his broader cross-ticker track record, Horowitz's prior sells have not exhibited well-timed exits at the 90-day measurement point, though his buys show strong timing with 88.89% win rate and +21.1% average 90-day return. This filing provides a material disclosure of significant share reduction by a director during a period of recent stock strength.

Director Joshua Horowitz buys 17,096 shares at $2.28 avg (2 txns): $38,927.31 in BRN stock near 52-week lows

Joshua Horowitz, a director at Barnwell Industries, made 2 separate open-market purchases totaling 17,096 shares (17.1K shares) for $38,927.31 ($38.9K) at a blended average price of $2.28, increasing his holdings by 6.8% to 270,276 shares (270.3K shares). The purchases occurred near the lower end of the 52-week range ($2.17–$2.95), with the current price at $2.32 down 21.4% from the 52-week high and down 15.9% over 90 days. Historically, Horowitz's prior purchases at Barnwell Industries show strong timing: 4 of 5 prior buys delivered positive 90-day returns, with cumulative 90d gains of +23.8%, +26.0%, +30.9%, +7.0% across those trades. However, the company context is challenging—latest quarterly revenue was $5,527,000.00 ($5.5M) with a net loss of $1,246,000.00 ($-1.2M), and annual revenue declined 11.5% year-over-year. The purchase volume and price level suggest consistent accumulation in a structurally challenged micro-cap, though the insider's prior success at timing these positions at Barnwell warrants observation of whether that pattern persists.

Director Joshua Horowitz bought 5,034 shares at $18.83 avg (Aug 15-19), reaching 90,000 shares post-transaction at BKTI.

Director Joshua Horowitz made 2 separate purchases totaling 5,034 shares for $94,791.34, adding 5.9% to his holdings and bringing total position to 90,000 shares. The timing aligns with positive momentum: BKTI trades at $19.65, up 50.1% over 30 days and 39.1% over 90 days, near its 52-week high. His same-ticker history shows all 5 prior BKTI buys were well-timed at the 90-day mark, with gains ranging from 18.9% to 26.7%. However, his cross-ticker track record (13 prior buys) shows more modest 30-day performance (+2.3% average) and the company itself remains unprofitable on a full-year basis despite strong 45.4% annual revenue growth. The accumulation into strength and proven execution at this ticker merit investor attention, though current valuation (P/E 25.52) and overall profitability profile warrant scrutiny.

Horowitz (Director) sells 26,400 shares across 7 transactions for $1,560,355.92 at LMB (blended avg $59.10).

Director Joshua Horowitz executed 7 separate sales totaling 26,400 shares for $1,560,355.92 over three trading days (Aug 13–15), reducing his holdings by 10.6% from 249,672 to 223,272 shares. The blended average sale price of $59.10 is marginally below the current price of $59.12, placing these sales near recent market valuations. While the transaction size and multi-day execution structure suggest deliberate liquidation, the modest value relative to the company's $666.5M market cap and the insider's strong historical performance (75% win rate with 13.8% average 90-day return across all prior open-market trades) do not signal fundamental concern. The stock is -9.6% from its 52-week high but up 23.8% over 90 days, maintaining a reasonable technical position.